SFA
IBRX icon

Sequoia Financial Advisors’s ImmunityBio IBRX Stock Holding History

Sequoia Financial Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
27,658
+915
+3% +$6.93K ﹤0.01% 1841
2026
Q1 		$205K Sell
26,743
-2,040
-7% -$14K ﹤0.01% 1782
2025
Q4 		$57K Buy
28,783
+3,871
+16% +$8.77K ﹤0.01% 1894
2025
Q3 		$61.3K Buy
24,912
+4,852
+24% +$12.5K ﹤0.01% 1709
2025
Q2 		$53K Sell
20,060
-7
-0% -$19 ﹤0.01% 1557
2025
Q1 		$60.4K Buy
+20,067
New +$60.8K ﹤0.01% 1343

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sequoia Financial Advisors's IBRX Position: Q2 2026 in Review

Sequoia Financial Advisors increased its ImmunityBio (IBRX) stake by 3.4% in Q2 2026, buying an estimated $6.93K and bringing the position to 27,658 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1841.

Sequoia Financial Advisors first reported a position in IBRX in Q1 2025 and has held it in 6 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Sequoia Financial Advisors held 27,658 shares of ImmunityBio worth $242K as of Q2 2026.
  • Sequoia Financial Advisors bought 915 ImmunityBio shares in Q2 2026, an estimated $6.93K.
  • ImmunityBio made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1841 holding.
  • Sequoia Financial Advisors first reported a position in ImmunityBio in Q1 2025 and has held it in 6 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.